SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 93 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,452,000 | -8.7% | 112,200 | 0.0% | 0.01% | -14.3% |
| Q1 2016 | $1,591,000 | -10.9% | 112,200 | 0.0% | 0.01% | -12.5% |
| Q4 2015 | $1,785,000 | +34.0% | 112,200 | +29.1% | 0.01% | +33.3% |
| Q3 2015 | $1,332,000 | -19.4% | 86,900 | +29.3% | 0.01% | -14.3% |
| Q2 2015 | $1,652,000 | -89.9% | 67,200 | -90.5% | 0.01% | -89.7% |
| Q1 2015 | $16,418,000 | +2790.5% | 704,314 | +3016.4% | 0.07% | +2166.7% |
| Q4 2014 | $568,000 | -22.0% | 22,600 | -3.4% | 0.00% | -25.0% |
| Q3 2014 | $728,000 | +5.8% | 23,400 | -12.0% | 0.00% | +33.3% |
| Q2 2014 | $688,000 | +15.1% | 26,600 | +3.9% | 0.00% | 0.0% |
| Q1 2014 | $598,000 | +2.9% | 25,600 | +11.8% | 0.00% | 0.0% |
| Q4 2013 | $581,000 | -1.9% | 22,900 | -21.0% | 0.00% | 0.0% |
| Q3 2013 | $592,000 | +9.8% | 29,000 | +12.8% | 0.00% | 0.0% |
| Q2 2013 | $539,000 | – | 25,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
| HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
| ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
| THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
| Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
| Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
| Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
| JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
| Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |